Clinical trials
Active, not recruiting Cardiotoxicity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 4 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Dana-Farber Cancer Institute | 1 |
| Hospital Sirio-Libanes | 1 |
| Lucía Florio | 1 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| NHS Greater Glasgow and Clyde | 1 |
| Nova Scotia Health Authority | 1 |
| Ottawa Hospital Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 14 |
| Breast Neoplasms | 5 |
| Cardiovascular Diseases | 5 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Drug-Related Side Effects and Adverse Reactions | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Atherosclerosis | 1 |
| Hodgkin Disease | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.